Status:
COMPLETED
MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Infertility
Pain
Eligibility:
FEMALE
18-42 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess pain, at or after oocyte retrieval, the effectiveness of self-controlled inhalation analgesia by nitrous oxide (N2O of 50% and 50% O2) by the patient compared to...
Detailed Description
Oocyte retrieval is a major event during in VITRO-fertilization, with or without sperm micro-injection. Initially done by laparoscopy with general anesthesia, the oocyte collection is now carried out ...
Eligibility Criteria
Inclusion
- patient requiring a first or second oocyte retrieval procedure for IVR or ICSI after ovarian stimulation by gonadotrophin
- agreement to participate to this study
Exclusion
- absolute indication for oocyte retrieval with general anesthesia
- no agreement to participate to this study,
- painfully known patient-not easy ovarian vaginal accessibility for monitoring or puncture
- respiratory pathology-chronic liver, kidney pathology, immunodeficiency, -contraindication to the medications used during the protocol
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00853177
Start Date
November 1 2008
End Date
January 1 2011
Last Update
September 18 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jean Verdier, service de la médecine de la reproduction, avenue du 14 juillet
Bondy, Île-de-France Region, France, 93143